AFLURIA QUADRIVALENT 2023-2024 FORMULA PF CPT Vaccine Code: 90685
Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use
Vaccine & Product Overview
About AFLURIA QUADRIVALENT 2023-2024 FORMULA PF
Afluria Quadrivalent 2023-2024 Formula PF is a medication aligned to the HCPCS CPT Drug Code: 90685 for billing, pricing, and reimbursement purposes in the United States. Classified under Vaccine, it is administered via the oral route and manufactured by Seqirus Inc.
Manufacturers, reach out to us to add more information.
NDC Code Information
1 NDC package is crosswalked to 90685. Package detail is available to logged-in subscribers.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| •••••-••••-•• Log in to view | AFLURIA QUADRIVALENT 2023-2024 FORMULA PF | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
AFLURIA QUADRIVALENT 2023-2024 FORMULA PF Vaccine Administration Codes
Medicare bills the administration of AFLURIA QUADRIVALENT 2023-2024 FORMULA PF with HCPCS code G0008, and allows simplified roster billing when vaccinating multiple patients. The CPT codes below apply to non-Medicare payers.
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| Code | Description |
|---|---|
| G0008 | Administration of influenza virus vaccine (Medicare) |
| 90460 | Immunization administration via any route, first vaccine/toxoid component |
| 90461 | Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component (List separately in addition to code for primary procedure). |
AFLURIA QUADRIVALENT 2023-2024 FORMULA PF Medically Unlikely Edits (MUE)
The most billing units of 90685 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.25 ml.
MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →
AFLURIA QUADRIVALENT 2023-2024 FORMULA PF Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there a manufacturer-published billing and coding guide for Afluria Quadrivalent 2023-2024 Formula Pf?
Are there any available patient assistance programs for Afluria Quadrivalent 2023-2024 Formula Pf?
Where can I find Afluria Quadrivalent 2023-2024 Formula Pf prescribing information?
Is there available side effect information for Afluria Quadrivalent 2023-2024 Formula Pf?
Does billing AFLURIA QUADRIVALENT 2023-2024 FORMULA PF require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to AFLURIA QUADRIVALENT 2023-2024 FORMULA PF.
